Company Overview

Development Stage

About the Company

[Summary] 解决中国和世界器官移植供体严重短缺的问题

启函生物于2017年成立于中国杭州,是一家将高通量基因编辑技术应用于细胞治疗和器官移植领域的生物科技公司。启函生物希望利用其高通量的基因编辑技术和对免疫移植知识的深刻理解开发出免疫兼容的同种异体细胞治疗和异种器官疗法,为世界上千千万万的病人及家属带来希望,启函治病救人的理念和科技获得国内外资本青睐,融资金额超过2亿人民币,由红杉资本,招银国际,Arch Venture Partners,北极光创投等国内外知名投资机构投资。目前公司的同种异体细胞治疗产品处于研究者发起的临床试验阶段,正在准备国家药品监督管理局临床试验申请。2019年启函生物被麻省理工科技评论评为“聪明的50个高科技公司”。
更多关于启函生物的介绍请访问公司官网

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

启函生物 Financing History (5 rounds)

Manage
Pre-B轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 数亿人民币
  • Investor: 浙江金控资本,红杉资本中国...

启函生物 Recruitment Overview / Current Status (28 open positions)

Manage
启函生物 Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
启函生物 Campus Recruitment & Advanced Degree Talent Demand
Master's 7 Doctorate 4
Note: How fast is hiring at 杭州启函生物科技有限公司 growing? 启函生物2026: 41 openings, 2025: 5 openings, 2023: 2 openings, 2022: 5 openings, 2021: 1 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

启函生物 Master's Degree Job Demand Analysis

(More)
启函生物 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 杭州启函生物科技有限公司 growing? 启函生物Master's recruitment over the years: 2025: 1 openings, 2023: 1 openings, 2022: 3 openings.

启函生物 Doctoral Degree Job Demand Analysis

(More)
+900%
Growth Rate
2026 vs 2025
启函生物 Doctoral Hiring by Year: 2026 — 9 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 杭州启函生物科技有限公司 growing? 启函生物Doctorate recruitment over the years: 2026: 10 openings, 2025: 1 openings, 2022: 1 openings, 2021: 1 openings.

启函生物 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 杭州启函生物科技有限公司? Based on an analysis of 启函生物's job postings over the past year, "科研类" demand: 37.5%, "其他(研发和技术类)": 31.3%, "生物/制药/化工/环保类": 18.8%, "医疗卫生/美容保健类": 12.5%, "电子/电器/通信技术类": 6.3%, "机械/仪器仪表类": 3.1%. For reference only.

启函生物 — What Are the Salaries Like? (32 records)

Manage
启函生物 Salary Overview
salary range: 2K - 50K, 59.4% of roles pay ¥2-8K
Note: salary statistics are based on 32 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 杭州启函生物科技有限公司?启函生物59.4% of positions earn 2-8K, Undergraduate salary: ¥。科研类 average salary ¥18.9K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 启函生物

(More)
Are salaries high at 杭州启函生物科技有限公司? We provide: 科学家,研究专员,研究员,qc,临床,分析,普工,会计,开发负责人,运营,analyst,ea,内审,检测,检验,知识产权,质量,采购,项目管理,高级专员. Click to view detailed salary analysis by job.

启函生物 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

启函生物 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 科研类
    37.8% of total 37.8%
  • 其他(研发和技术类)
    26.7% of total 26.7%
  • 生物/制药/化工/环保类
    26.7% of total 26.7%
  • 质量管理类
    22.2% of total 22.2%

Education

  • 本科
    44.4% of total 44.4%
  • 硕士
    24.4% of total 24.4%
  • 博士
    22.2% of total 22.2%
  • 不限
    6.7% of total 6.7%

Experience

  • 1-3年
    42.2% of total 42.2%
  • 3-5年
    28.9% of total 28.9%
  • 5-10年
    17.8% of total 17.8%
  • 不限
    11.1% of total 11.1%
View Detailed Analysis

What does 杭州启函生物科技有限公司 require? Who is 启函生物 hiring? 启函生物 recruitment: 科研类占比最多占37.8%,其次是其他(研发和技术类)占26.7%. What education can get in at 启函生物? 本科占比最多占44.4%,其次是硕士占24.4%. High education required at 启函生物? 硕士占24.4%,博士占22.2%. Work experience required at 启函生物? 1-3年占比最多占42.2%,其次是3-5年占28.9%. Where are the job locations at 启函生物? 杭州占比最多占91.1%,其次是眉山占4.4%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 10万(元)
Legal Representative: 丁萍妃
Date Established:
Credit Code: 91330109MA2AY3W152
Registered Address: 浙江省杭州市萧山区经济技术开发区传化科创大厦1幢萧山科技城202-54室

Partners & Suppliers

共建基因编辑与细胞治疗联合实验室,合作开发通用型CAR-T等细胞药物 Source
供应商 抗肿瘤新药研发
共同开发异种移植基因编辑猪,共享技术和知识产权 Source
供应商 战略合作
联合建立基因编辑研究中心,开展基础研究与人才培养 Source
供应商 高校/研究院
技术授权与合作研发,提供基因编辑技术许可和基础研究支持 Source
供应商 高校/研究院

People who follow 启函生物 also follow

启函生物 Competitors (Similar Companies)

精准医疗 药物研发 免疫治疗 科学研究
“干细胞再生技术创新的高科技生命健康企业。”
制药/药业 医药工业 研发 医药科技
“Research, development, and production of anti-tumor and surgical medic”
眼线笔 化妆笔 眉笔 唇笔
“Dedicated to the research, development, production, and commercializat”
“让原创药禧济天下”
研发 制药/药业 圆螺母 制药行业解决方案
“To produce more affordable and effective medicines for the Chinese peo”
“人体组织工程器官修复器械研发企业”
“Core Mission: Safeguarding Human Health with Life Sciences”
新药研发 医疗器械 检测设备 生产
制药/药业 医药 日化 儿科用药
“Copper and copper alloy material supplier”
“To develop high-quality biologics that are accessible and affordable f”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates